Laurus Labs announced its first-time inclusion in the Dow Jones Best-in-Class World Index for strong ESG performance.
The company achieved an S&P Global CSA score of 81/100 in pharmaceuticals, up from 71/100 in the previous year.
This recognition enhances the company's credibility with global investors and reflects its sustainable business practices.